Results 1 to 10 of about 204,163 (273)
Infections occur frequently in oncological and transplant settings and are complicated due to several factors not limited to the degree of immunosuppression, healthcare exposure, and antimicrobial resistance.
Vidya Krishna, Jui Athavale-Wad
doaj +9 more sources
For better management of patients with febrile neutropenia, our study investigated the epidemiologic, microbiologic, and clinical characteristics of adult inpatients with febrile neutropenia and their mortality-associated factors. To this end, we carried
Roberto L Parodi +9 more
doaj +2 more sources
Objectives: No recent studies are available from Saudi Arabia on the etiology of febrile neutropenia. The objective of this study was to describe the characteristics of patients with febrile neutropenia and to calculate the rate of occurrence of ...
Jaffar A. Al-Tawfiq +7 more
doaj +2 more sources
Background The docetaxel, 5-fluorouracil, and cisplatin (DCF) regimen is an effective form of chemotherapy for advanced esophageal cancer. However, the incidence of adverse events such as febrile neutropenia and hematological toxicity is high.
Yu Ohkura, Masaki Ueno, Harushi Udagawa
doaj +2 more sources
Background: Febrile neutropenia (FN) is an oncologic emergency which should be treated immediately with empiric antibiotics. Different institutions observe different antibiograms and use different FN management guidelines.
Doaa Naeem +3 more
doaj +2 more sources
Empiric Imipenem/Cilastatin/Relebactam for Febrile Neutropenia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports [PDF]
Dao-Xing Deng,* Ting Wang,* Hui Sun,* Jun Kong, Yuan-Yuan Zhang, Le-Qing Cao, Xiao-Dong Mo Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center
Deng DX +6 more
doaj +2 more sources
Comprehensive evaluation of risk factors for the development and complications of chemotherapy-induced febrile neutropenia [PDF]
Febrile neutropenia is a serious adverse effect of chemotherapy. It can lead to complications and death, as well as delays in treatment, chemotherapy dose reductions, compromised treatment efficacy, and reduced survival.
Dimitrijević Jelena +3 more
doaj +1 more source
Prophylaxis and management of chemotherapy-induced febrile neutropenia: The role of myeloid growth factors [PDF]
Febrile neutropenia is a serious chemotherapy-related adverse event that can lead to complications and death and it could be a significant burden on the organization of the health care system.
Dimitrijević Jelena, Stojanović Marko
doaj +1 more source
Febrile neutropenia in the emergency department
Introduction: Febrile neutropenia is one of the most common presentations to the emergency department. Identification and empirical antibiotic therapy improve the outcome of these patients.
Malle Simeon +2 more
doaj +1 more source
Chimeric Antigen Receptor T cells (CAR-T) are an outbreaking treatment option for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are the ...
R. Lievin +14 more
semanticscholar +1 more source

